PJC
RMD icon

Phillip James Consulting’s ResMed RMD Stock Holding History

Phillip James Consulting’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$780 Buy
+4
New +$829 ﹤0.01% 294

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Phillip James Consulting's RMD Position: Q2 2026 in Review

Phillip James Consulting opened a new position in ResMed (RMD) in Q2 2026: 4 shares worth $780. The stake represents ﹤0.01% of the portfolio and ranks #294 among its holdings.

880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Phillip James Consulting held 4 shares of ResMed worth $780 as of Q2 2026.
  • ResMed was a new Phillip James Consulting position in Q2 2026.
  • ResMed made up ﹤0.01% of Phillip James Consulting's portfolio in Q2 2026, its #294 holding.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Phillip James Consulting's 13F filing for Q2 2026, filed 28 Jul 2026.